Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added and the previous revision v3.3.3 was removed in the study record history, reflecting internal version updates rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-01-14T03:30:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new revision entry: Revision: v3.3.3. Removed HHS Vulnerability Disclosure and the older Revision: v3.3.2 from the page.
    Difference
    0.2%
    Check dated 2025-12-23T20:22:24.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision history shows the addition of version v3.3.2 and the removal of v3.2.0. This appears to be routine maintenance of the study record history and does not change study content.
    Difference
    0.1%
    Check dated 2025-11-24T21:56:22.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding notice banner was removed, so the page no longer displays the operating-status message; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-17T19:58:58.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The screenshot shows only a minor visual refresh of the page header and layout, with no changes to the version history data or study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T13:53:40.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.
    Difference
    11%
    Check dated 2025-10-06T04:25:22.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.